Trials / Completed
CompletedNCT00612027
Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 29,586 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. general practitioners and internists) are asked to document relevant data related to esomeprazole therapy in patients with gastrointestinal disorders. Patients with acid associated gastrointestinal symptoms can be included.
Conditions
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2006-03-01
- First posted
- 2008-02-11
- Last updated
- 2008-02-11
Source: ClinicalTrials.gov record NCT00612027. Inclusion in this directory is not an endorsement.